Executive Orders and Policy Updates - In the end of 2025 and the first quarter of 2026, the Trump administration and federal ...

Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted.

The Food and Drug Administration’s flagship internal AI tool, Elsa, is being integrated with the data platform so that staff ...

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Food and Drug Administration (FDA) is facing scrutiny over how ...

In June 2025, several mainstream media outlets reported a surge in U.S. drug overdose deaths in early 2025 that was based on data from the U.S. Centers for Disease Control and Prevention (CDC). A new ...

Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...

The US Food and Drug Administration (FDA) has released draft guidance aimed at assisting pharmaceutical manufacturers in transitioning from animal studies to non-animal alternatives for drug ...

The U.S. Food and Drug Administration has issued a warning letter to Novo Nordisk, accusing the Danish drugmaker behind blockbuster medications Ozempic and Wegovy of failing to properly report serious ...

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, ...

Novo Nordisk said on Tuesday it had received a warning letter from the U.S. Food and Drug Administration regarding an inspection at the Danish drugmaker's site in Plainsboro, New Jersey in early 2025.

COPENHAGEN, March 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday it had received a warning letter from the U.S. Food and Drug Administration regarding an inspection at the ...